RxDoctor Payments Data

Paul Dayton, DPM

Podiatrist · Ankeny, IANPI 1558333914

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $8,065,484 of the $9,408,424 with a category attached, or 85.7%. Treace Medical Concepts, Inc. accounts for 100.0% of it on its own, with 12 other manufacturers making up the rest. Among podiatrist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,408,424in general payments, 2019–2025

Across 1,186 payments — averaging $7932.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$9.4M
  • Fusion Orthopedics USA, LLC$564
  • Stryker$484
  • AbbVie$140
  • Orthofix Medical, Inc.$139
  • Mimedx Group, Inc.$86
  • plus $276 from 7 others
$284,584in research payments, 2019–2025

Across 123 payments — averaging $2313.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Treace Medical Concepts, Inc.$285K

What the payments were for

  • Royalty or licence$8,065,48486%
  • Consulting fees$1,174,62412%
  • Speaking & faculty fees$120%
  • Travel & lodging$140,6921%
  • Food & beverage$27,6120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,408,424 in reported general payments places this provider in the 95th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$99,291
Medicare patients
187
Services billed
943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levofloxacin15$74
Gabapentin28$57
Oxycodone Hcl23$49

Paid to pharmacies, not to this prescriber.

Other podiatrist in Ankeny

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →